San Francisco, January 12, 2023 /PRNewswire/ — Vial, a technology-enabled CRO that provides next-generation clinical trial management services, has announced the addition of Jacqueline French, MD, as a new CNS Scientific Advisor for its Neurology CRO.
Dr. French is Professor of Neurology at NYU Grossman School of Medicine, Co-Director of Epilepsy Clinical Trials at NYU Langone Health’s Comprehensive Epilepsy Center, and President, Director and Founder of The Epilepsy Study Consortium. After receiving his medical education at Brown University, he completed a neurology residency at Mount Sinai Hospital in New York. She then received further training at Mount Her Sinai Hospital and Yale University through a fellowship in EEG and Epilepsy.
Dr. French has over 30 years of experience in the fields of neurology and epilepsy. Her research focuses on epilepsy treatment and creating new clinical trial designs. She has also contributed to the development of treatment guidelines for the American Academy of Neurology (AAN) and the International Federation of Antiepilepsy.
“As we advance our neurology CRO, now is the right time to augment our CNS SAB expertise to support our evolution as the next generation of technology-enabled CROs.Welcome Dr. French We are excited to be doing this,” said Simon Burns, CEO and Co-Founder of Vial.
“Vial’s approach to clinical trials represents a promising avenue for treating diseases that affect millions of patients. Collaborating with leading-edge teams to reimagine clinical trials for drug discovery.” I look forward to doing so,” said Dr. French.
For more information on Vial, please visit our website.
Read the full release here.
About Vial: Vial is a next-generation, technology-enabled CRO that promises faster, higher-quality clinical trial execution. The Vial Contract Research Organization (CRO) delivers on the promise of more efficient trials through an innovative technology platform that powers trials end-to-end from site launch to database lock. The key to Vial’s technology-enabled platform is Vial’s modern, intuitive electronic sources and powerful tools for CRAs that enable significant efficiencies. Vials operates across multiple therapeutic areas (dermatology CRO, ophthalmology CRO, oncology CRO, gastroenterology CRO, neurology CRO, and cardiology CRO). Vial is a company based in San Francisco, California with over 125 employees.
View original content and download multimedia: https://www.prnewswire.com/news-releases/vial-announces-new-central-nervous-system-scientific-advisory-board-member-dr-jacqueline- french-of-the-epilepsy-study-consortium-and-nyu-grossman-school-of-medicine-301720808.html